March 13, 2022 - The NASH Podcast - Surfing the NASH Tsunami Podcast

S3-E14.4 – Ballooned Hepatocyte Analysis and Reassessing Drug Development

This Episode is Sponsored By HistoIndex: How can a reassessment of the way we analyze ballooned hepatocyte cells in clinical trials reshape drug development practices and the success rates in clinical trials?

March 13, 2022

Day: March 13, 2022

All Podcast Categories

S3-E14.4 – Ballooned Hepatocyte Analysis and Reassessing Drug Development

Discussion Group

Join The Discussion in our LinkedIn or Facebook Discussion Groups

Join The Live Recordings

Recording for this session will take place at 3:15p Eastern US time (1900H CET, 1800H BT) on Monday.

Join The Discussion…

NASH & Diabetes Podcast and NASH Tsunami Podcast

S1-E1.2 – NAFLD Prevalence and Type 2 Diabetes in an Endocrinology Clinic: The Need for Screening and Vigilance

S3-E41 – Improving NASH Clinical Trials By Reducing Screen Fail Rates

S3-E40.5 – From the Vault: Why Cirrhosis Matters In Clinical Trial Strategy

S3-E40.4 – Challenges of Alcohol Screening in Fatty Liver Disease

S3-E40.3 – Importance of Early Diagnosis in Lean NASH

S3-E40.2 – A Simple Diagnostic Algorithm for Lean NASH

S3-E40.1 – Best Practices in Lean NASH: How the Article Came About

S3-E40 – Best Practices in Lean NASH: Authors Provide Back Story

S3-E39.5 – From The Vault: Early, Accurate Patient Information Matters

S3-E39.4 – Patient Follow-Up Challenges in Modeling NASH Diagnostics

S3-E39.3 – NASH Challenges: Early Diagnosis & NASH Patient Management

Experience Nudge Learning!
Interested in a new way of learning?